These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 23467393)

  • 1. Endometrioid endometrial carcinoma indirectly caused by pituitary prolactinoma: a case report.
    Nishino K; Niwa Y; Mizutani T; Shimizu K; Hayashi K; Chaya J; Kato N; Yamamuro O
    Case Rep Oncol; 2013 Jan; 6(1):25-30. PubMed ID: 23467393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synchronous endometrial carcinoma and a macroprolactinoma: exploring a causal relationship.
    Sharma A; Sharma MS; De Padua M; Jha UP; Jha AN
    Oncology; 2007; 72(1-2):139-42. PubMed ID: 18025806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of levonorgestrel-releasing intrauterine device on hormonal profile and menstrual pattern after long-term use.
    Xiao B; Zeng T; Wu S; Sun H; Xiao N
    Contraception; 1995 Jun; 51(6):359-65. PubMed ID: 7554977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Onapristone (ZK 98.299): a potential antiprogestin for endometrial contraception.
    Katkam RR; Gopalkrishnan K; Chwalisz K; Schillinger E; Puri CP
    Am J Obstet Gynecol; 1995 Sep; 173(3 Pt 1):779-87. PubMed ID: 7573244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hemorrhages in abnormal production of gonadotropins].
    Nilsen PA
    Tidsskr Nor Laegeforen; 1976 Sep; 96(26):1374-8. PubMed ID: 968885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adolescent menstrual irregularity.
    Mansfield MJ; Emans SJ
    J Reprod Med; 1984 Jun; 29(6):399-410. PubMed ID: 6379175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Menstrual disorders associated with hyperprolactinemia.
    Caufriez A
    Horm Res; 1985; 22(3):209-14. PubMed ID: 3902608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between hyperprolactinemia, MRI of hypophysis and clinical presentation in infertile patients.
    Godinjak Z; Idrizbegovic E; Rama A
    Med Arch; 2013; 67(1):22-4. PubMed ID: 23678832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of ovulation in women by chronic treatment with a stimulatory LRH analogue--a new approach to birth control?
    Nillius SJ; Bergquist C; Wide L
    Contraception; 1978 Jun; 17(6):537-45. PubMed ID: 352612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mode of action of RU 486.
    Bygdeman M; Swahn ML; Gemzell-Danielsson K; Svalander P
    Ann Med; 1993 Feb; 25(1):61-4. PubMed ID: 8435191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endometrial patterns in women on chronic luteinizing hormone-releasing hormone agonist treatment for contraception.
    Bergquist C; Nillius SJ; Wide L; Lindgren A
    Fertil Steril; 1981 Sep; 36(3):339-42. PubMed ID: 6793403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interruption of endometrial maturation without hormonal changes by an antiprogesterone during the first half of luteal phase of the menstrual cycle: a contraceptive potential.
    Greene KE; Kettel LM; Yen SS
    Fertil Steril; 1992 Aug; 58(2):338-43. PubMed ID: 1633899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of a sequential regimen of mifepristone-medroxyprogesterone acetate on ovarian function, endometrial development and hormonal parameters.
    Croxatto HB; Massai MR; Salvatierra AM; Fuentealba B; Croxatto HD; Lähteenmäki P
    Contraception; 1996 Aug; 54(2):79-86. PubMed ID: 8842583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocrinology of female infertility.
    Baird DT
    Br Med Bull; 1979 May; 35(2):193-8. PubMed ID: 387167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High prevalence of subtle and severe menstrual disturbances in exercising women: confirmation using daily hormone measures.
    De Souza MJ; Toombs RJ; Scheid JL; O'Donnell E; West SL; Williams NI
    Hum Reprod; 2010 Feb; 25(2):491-503. PubMed ID: 19945961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The pulsatile LH fluctuation (spiking) dependent on the circulating prolactin. Studies during physiological (puerperium), functional pathological and TRH induced hyperprolactinemia].
    Bohnet HG; Wiest HJ; Dahlén HG; Schneider HP
    Endokrinologie; 1975 Nov; 66(2):158-72. PubMed ID: 819256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of first cycles in primary hypothalamic amenorrhea with pulsatile luteinizing hormone-releasing hormone: a mirror of female pubertal development.
    Schoemaker J; van Kessel H; Simons AH; Korsen TJ
    Fertil Steril; 1987 Aug; 48(2):204-12. PubMed ID: 3111891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endometrial cathepsin D immunostaining throughout ovulatory and anovulatory menstrual cycles.
    Camier B; Hedon B; Rochefort H; Maudelonde T
    Hum Reprod; 1996 Feb; 11(2):392-7. PubMed ID: 8671230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A biochemical test for the direct assessment of endometrial function: measurement of the major secretory endometrial protein PP14 in serum during menstruation in relation to ovulation and luteal function.
    Fay TN; Jacobs IJ; Teisner B; Westergaard JG; Grudzinskas JG
    Hum Reprod; 1990 May; 5(4):382-6. PubMed ID: 2362002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progestogens versus oestrogens and progestogens for irregular uterine bleeding associated with anovulation.
    Hickey M; Higham J; Fraser IS
    Cochrane Database Syst Rev; 2000; (2):CD001895. PubMed ID: 10796833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.